<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">medsovet-7635</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НОВОСТИ. ОТКРЫТИЯ И СОБЫТИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NEWS, DISCOVERIES AND EVENTS</subject></subj-group></article-categories><title-group><article-title>Алла Сергеевна Аведисова:  «Чем раньше начато лечение депрессии,  тем меньше риск нежелательных последствий  и эффективнее фармакотерапия»</article-title><trans-title-group xml:lang="en"><trans-title>Alla S. Avedisova:  “The earlier the treatment of depression  is started, the lower the risk of adverse effects  and the more effective pharmacotherapy”</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редакционная</surname><given-names>статья</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>21</day><month>07</month><year>2023</year></pub-date><volume>0</volume><issue>10</issue><fpage>9</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Редакционная с., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Редакционная с.</copyright-holder><copyright-holder xml:lang="en">Редакционная с.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/7635">https://www.med-sovet.pro/jour/article/view/7635</self-uri><abstract><p>Интервью с главным научным сотрудником Отдела пограничной психиатрии ФГБУ «Национальный медицинский исследова- тельский центр психиатрии и  наркологии им.  В.П. Сербского» Минздрава России, главным научным сотрудником ГБУЗ «Научно-практический психоневрологический центр им. З.П. Соловьева Департамента здравоохранения Москвы», заслужен- ным врачом России, доктором медицинских наук, профессором Аллой Сергеевной Аведисовой.</p></abstract><trans-abstract xml:lang="en"><p>Interview with Alla S. Avedisova, Dr. of Sci. (Med.), Professor, Chief Researcher of the Department of Borderline Psychiatry, Federal State Budgetary Institution V.P. Serbsky National Medical Research Centre for Psychiatry and Narcology of the Ministry of Health Russian Federation, State Budgetary Healthcare Institution Z.P. Solovyev Research and Practical Psychoneurology Center of Moscow Department of Healthcare, Honoured Doctor of Russia.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
